Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Ken Griffin, the co-founder and CEO of Citadel LLC, has slashed his Palantir stock holdings by 91%, as revealed by a recent ...

We recently compiled a list of the 10 Best Prison and Law Enforcement Stocks To Invest In. In this article, we are going to ...

Billionaire Israel Englander is the founder and CEO of Millennium Management, the second-most profitable hedge fund in ...

Policy stances from the incoming Trump administration, bullish quarterly earnings and an “Elon Musk premium” led to lofty ...

Jefferies has an Underperform rating on Palantir and a price target of $28; PLTR shares are changing hands for $62.2 in Tuesday's early market trading. This article first appeared on GuruFocus.

Palantir (NYSE:PLTR) shares have performed remarkably well in 2024, with shares increasing more than 250% year to date as the ...

Among those selling the stock was CEO Alex Karp, who filed to sell 4.5 million shares of the stock on Friday, which has a ...

We recently compiled a list of the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2024. In this article, we are going to ...

During the third quarter, billionaire Ken Griffin cut Citadel's stake in Palantir by 91% while increasing his hedge fund's ...

For a stock growing its revenue by around 30%, that valuation is pretty extreme. While Palantir is a great company, at some ...

We recently compiled a list of the Jim Cramer’s Best Performers List: Top 10 Stocks. In this article, we are going to take a ...